Literature DB >> 17634712

Chronic cholesterol crystal embolism with a spontaneous onset.

Mio Enomae1, Shin-ichi Takeda, Keiichi Yoshimoto, Kiyoshi Takagawa.   

Abstract

A 74-year-old man was referred to our hospital because of hypertension, blue toe syndrome and an elevation of serum creatinine from 0.8 to 1.4 mg/dl for eleven months. He had no history of invasive vascular procedures. Atherosclerosis was initially suspected, but renal impairment was accelerated following anticoagulant therapy. A renal biopsy established the diagnosis of cholesterol crystal embolism. Withdrawal of anticoagulants and the combination therapy with LDL apheresis and corticosteroids led to stabilization of the renal function. In patients with risk factors for atherosclerosis, cholesterol crystal embolism should be included in the differential diagnosis of chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634712     DOI: 10.2169/internalmedicine.46.0102

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Low-density lipoprotein apheresis ameliorates monthly estimated glomerular filtration rate declines in patients with renal cholesterol crystal embolism.

Authors:  Keiji Hirai; Susumu Ookawara; Haruhisa Miyazawa; Kiyonori Ito; Yuichirou Ueda; Yoshio Kaku; Taro Hoshino; Izumi Yoshida; Kaoru Tabei
Journal:  J Artif Organs       Date:  2014-11-04       Impact factor: 1.731

2.  Low-density lipoprotein apheresis for corticosteroid-resistant skin lesions caused by cholesterol crystal embolism: a case report and review of the literature.

Authors:  Hiroki Kobayashi; Masanori Abe; Yusuke Murata; Takashi Maruyama; Tetsuya Furukawa; Osamu Oikawa; Kazuyoshi Okada
Journal:  J Artif Organs       Date:  2015-03-28       Impact factor: 1.731

3.  Cholesterol Crystal Embolism Induced by Direct Factor Xa Inhibitor: A First Case Report.

Authors:  Hideaki Oka; Taro Kamimura; Yuki Hiramatsu; Kento Fukumitsu; Rei Iwata; Mika Kondo; Yutaro Hirashima; Seishi Aihara; Atsumi Harada; Kazuhiko Tsuruya
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.